Highly Vaccinated Asian Patients Did Not See Increased Diabetes Risk Post-COVID-19, Study Finds

MedPage Today (4/2, Monaco) reports a study suggests “there was no overall increased risk of new-onset type 2 diabetes after SARS-CoV-2 infection in a highly vaccinated and boosted Asian cohort when milder COVID-19 variants were predominant.” Compared to people who were not infected, “new-onset type 2 diabetes risk wasn’t significantly higher during either Delta or Omicron predominance from September 2021 to December 2022.” Researchers also found “that during the Delta wave, Indian individuals had a 29% higher risk for new-onset diabetes after infection; this risk wasn’t reported in Chinese or Malay individuals. During Omicron, no ethnic subgroup stood out as having a higher diabetes risk.” The study was published in JAMA Network Open.